These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6894360)

  • 1. Muscarinic receptor: multiple sites or unitary concept?
    Laduron PM; Leysen JE; Gorissen H
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):319-21. PubMed ID: 6894360
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscarinic receptors in the stomach.
    Hammer R
    Scand J Gastroenterol Suppl; 1980; 66():5-11. PubMed ID: 6941378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirenzepine--a ligand with original binding properties to muscarinic receptors.
    Birdsall NJ; Burgen AS; Hammer R; Hulme EC; Stockton J
    Scand J Gastroenterol Suppl; 1980; 66():1-4. PubMed ID: 6941372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3h]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex.
    Watson M; Roeske WR; Yamamura HI
    Life Sci; 1982 Nov; 31(18):2019-23. PubMed ID: 6897437
    [No Abstract]   [Full Text] [Related]  

  • 5. Axonal flow of muscarinic receptors.
    Laduron P
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):338-40. PubMed ID: 6157371
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization.
    Kloog Y; Egozi Y; Sokolovsky M
    Mol Pharmacol; 1979 May; 15(3):545-58. PubMed ID: 492145
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical studies on muscarinic receptors.
    Massoulié J; Godwin S; Carson S; Kato G
    Biomedicine; 1977 Jul; 26(4):250-9. PubMed ID: 579159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecific in vitro binding of [3H]dexetimide to brain muscarinic receptors.
    Laduron PM; Verwimp M; Leysen JE
    J Neurochem; 1979 Feb; 32(2):421-7. PubMed ID: 762557
    [No Abstract]   [Full Text] [Related]  

  • 11. The theory, methods and relevance of muscarinic receptor binding studies.
    Stockton J; Birdsall NJ; Burgen AS; Hulme EC
    Scand J Gastroenterol Suppl; 1982; 72():43-7. PubMed ID: 6957996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic binding to mouse brain receptor sites.
    Kloog Y; Sokolovsky M
    Biochem Biophys Res Commun; 1978 Apr; 81(3):710-7. PubMed ID: 666785
    [No Abstract]   [Full Text] [Related]  

  • 13. The affinity of pirenzepine and other antimuscarinic compounds for pre- and postsynaptic muscarine receptors of the isolated rabbit and rat heart.
    Fuder H
    Scand J Gastroenterol Suppl; 1982; 72():79-85. PubMed ID: 6958000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and subcellular localization of brain muscarinic receptors labelled in vivo by [3H]dexetimide.
    Laduron PM; Janssen PF
    J Neurochem; 1979 Dec; 33(6):1223-31. PubMed ID: 552402
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of [3H]dexetimide binding by a homologous series of methylfurthrethonium analogues at the peripheral muscarinic receptor.
    Beld AJ; Klok EJ; Rodrigues de Miranda JF
    Biochem Biophys Res Commun; 1980 Nov; 97(2):430-6. PubMed ID: 7470106
    [No Abstract]   [Full Text] [Related]  

  • 17. The binding of antagonists to brain muscarinic receptors.
    Hulme EC; Birdsall NJ; Burgen AS; Mehta P
    Mol Pharmacol; 1978 Sep; 14(5):737-50. PubMed ID: 714022
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective labelling of M1-receptors in autonomic ganglia with 3H-pirenzepine.
    Giraldo E; Monferini E; Hammer R
    Arzneimittelforschung; 1985; 35(1A):325-8. PubMed ID: 3838676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.